Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy
This article was originally published in The Tan Sheet
Executive Summary
A Pharmavite executive outlined a “different perspective” from the conventional wisdom promoted by FDA on successful compliance with dietary supplement good manufacturing practices: an emphasis on finished product specifications.
You may also be interested in...
GMP Qualification And Testing Provisions Still Trip Supplement Firms
A year after the final step in the three-year rollout of the dietary supplement good manufacturing practices final rule, firms large and small are learning the hard way what FDA expects to find in a facility.
FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.